Clinical trialNCT04305691RecruitingPhase 2Interventional

Trial of Ixazomib for Kaposi Sarcoma

SponsorAIDS Malignancy ConsortiumEnrollment41Kaposi SarcomaSkin

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Erin Reid, MD
AIDS Malignancy Consortium
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Uc San Diego
San Diego, California, United States
Erin Reid, MD
Recruiting
Zuckerberg San Francisco General Hospital
San Francisco, California, United States
Chia-Ching Wang, MD
Recruiting
University of Miami Miller School of Medicine
Miami, Florida, United States
Juan C Ramos, MD
Recruiting
University of Illinois Cancer Center
Chicago, Illinois, United States
Paul Rubinstein, MD
Recruiting
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
Richard Ambinder, MD
Recruiting
Washington University
St Louis, Missouri, United States
Lee Ratner, MD
Recruiting
Mount Sinai Hospital
New York, New York, United States
Philip Friedlander
Recruiting
Abramson Cancer Center at Pennsylvania Hospital
Philadelphia, Pennsylvania, United States
Daniel Lefler, MD
Recruiting
Thomas Street Clinic
Houston, Texas, United States
Recruiting
Thomas Street Clinic
Houston, Texas, United States
Elizabeth Chiao, MD, MPH
Recruiting
Virginia Mason Medical Center
Seattle, Washington, United States
David Aboulafia, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 Nov 2023
Primary completion: 15 Mar 2029
Completion: 15 Mar 2029
Last update posted: 27 Feb 2026
Registered enrollment: 41
Registry id: NCT04305691

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.